Using Real-World Data to Understand Patient Journeys in Dermatology
Listen to OM1’s podcast episode on the Medical Affairs Professional Society (MAPS) “Elevate” podcast series. Dr. Stefan Weiss is discussing ways to transform the way we conduct safety studies — relying more on EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety. Moving away from cumbersome and[…]
› LISTEN TO THE PODCASTPOSTERS
Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis Patients
DEC 2, 2022
View our poster on Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis Patients. Click to view!
Effect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical Practice
DEC 2, 2022
View our poster on Effect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical Practice. Click to view more!
NEWS & ARTICLES
Kazuki Yoshida, MD, MPH, ScD: Methotrexate Access in the Post-Roe v Wade Era
DEC 2, 2022
Published: December 1, 2022 Rheumatology Network Read the Full Article >> In the wake of the Supreme Court’s decision to overturn Roe v Wade, results of a recent study indicated that more than half of female patients treated with methotrexate, a commonly-prescribed drug used to manage rheumatic diseases, lived in states with abortion restrictions or[…]
Validation of a machine learning approach to estimate expanded disability status scale scores for multiple sclerosis
DEC 2, 2022
Published: June 22, 2022 Sage Journals Read the Full Article >> Background: Disability assessment using the Expanded Disability Status Scale (EDSS) is important to inform treatment decisions and monitor the progression of multiple sclerosis. Yet, EDSS scores are documented infrequently in electronic medical records. Objective: To validate a machine learning model to estimate EDSS scores[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
Advancing Personalized Medicine for Health Plans: How AI and RWE can improve outcomes, reduce costs, and improve member engageme
OCT 3, 2022
Tue, Oct 18, 2022 11:00 AM – 12:00 PM EDT Presenter: Joseph Zabinski, Senior Director, AI & Precision Medicine, OM1 Register >> As population health moves towards personalized, precision medicine, optimizing treatment options and reducing ineffective care will be critical to plans’ success and differentiation in highly competitive environments. Real-world evidence drawn from deep datasets[…]
Using Real-World Data to Unlock Better Outcomes in IBD & NASH Patients
JUL 19, 2022
Gastrointestinal and metabolic disorders are highly prevalent and result in reduced quality of life for many patients. Treatments are aimed at reducing symptoms and preventing complications and progression. More research is needed to better understand natural history and progression, treatment effectiveness, and outcomes. Register here Linked real-world data (RWD) and machine learning (ML) applications provide[…]